Neuroanatomical and neurochemical studies of the autistic brain: Current thought and future directions

Understanding Autism: From Basic Neuroscience to Treatment

Volumn , Issue , 2006, Pages 303-322

  Bauman, Margaret L ^a   Anderson, George ^b   Perry, Elaine ^c   Ray, Melissa ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952643170     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (109)

1. Ahlsen, G., Rosengren, L.E., Belfrage, M. et al., Fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders, Biol Psychiatry, 1993; 33: 734-743.
2. Anderson, G.M., Monoamines in autism: an update of neurochemical research on a pervasive developmental disorder, Med Biol., 1987; 65: 67-74.
3. Anderson, G.M., Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism, J Am Acad Child Adolesc Psychiatry, 2002; 12: 1513-1516.
4. Anderson, G.M., Gutknecht, L., Cohen, D.J. et al., Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia, Mol Psychiatry, 2002; 7: 831-836.
5. Anderson, G.M., Horne, W.C., Chatterjee, D. et al., The hyperserotonemia of autism, Ann N Y Acad Sci., 1990; 600: 331-340.
6. Anderson, G.M., Minderaa, R.B., Cho, S.C. et al., The issue of hyperserotonemia and platelet serotonin exposure: a preliminary study, J Autism Dev Disord., 1989; 19: 349-351.
7. Anderson, G.M., Zimmerman, A.W., Akshoomoff, N. et al., Autism clinical trials: biological and medical issues in patient selection and treatment response, CNS Spectrums, 2004; 9: 57-64.
8. 125 I-labelled 5HT 2A/2C receptors in the anterior cingulate cortex in control and autistic individuals, Presented at the 3rd International Meeting for Autism Research (IMFAR), May 7-8, 2004, Sacramento, CA.
9. Arin, D.M., Bauman, M.L., and Kemper, T.L., The distribution of Purkinje cell loss in the cerebellum in autism, Neurology, 1991; 41: 307 (abstract).
10. Bailey, A., Luthert, P., Dean, A. et al., A clinicopathological study of autism, Brain, 1998; 121: 889-905.
11. Bannon, A.W., Decker, M.W., Hilladay, M.W. et al., Broad-spectrum non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors, Science, 1998; 279: 77-81.
12. Barmack, N.H., Baughman, R.W., and Eckenstein, F.P., Cholinergic innervation of the cerebellum of the rat by secondary vestibular afferents, Ann NY Acad Sci., 1992; 656: 566-579.
13. Bauman, M.L. and Kemper, T.L., The brain in infantile autism: a histoanatomic report, Neurology, 1984; 34: 275 (abstract).
14. Bauman, M.L. and Kemper, T.L., Histoanatomic observations of the brain in early infantile autism, Neurology, 1985; 35: 866-874.
15. Bauman, M.L. and Kemper, T.L., Neuroanatomic observations of the brain in autism, in Bauman, M.L. and Kemper, T.L., Eds., The Neurobiology of Autism, Baltimore, MD: Johns Hopkins University Press, 1994, 119-145.
16. Bauman, M.L. and Kemper, T.L., Observations on the Purkinje cells in the cerebellar vermis in autism, J Neuropath Exp Neurol., 1996; 55: 613 (abstract).
17. Bauman, M.L. and Kemper, T.L., Structural brain anatomy in autism: what is the evidence?, in Bauman, M.L. and Kemper, T.L., Eds., The Neurobiology of Autism, 2nd ed., Baltimore, MD: Johns Hopkins University Press, 2005, 121-135.
18. Blatt, G.J., Fitzgerald, C.M., Guptill, J.T. et al., Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study, J Autism Dev Disord., 2000; 31: 537-543.
19. Carper, R.A., Moses, P., Tigue, Z.D. et al., Cerebral lobes in autism: early hyperplasia and abnormal age effects, Neuroimage, 2002; 16: 1038-1051.
20. Casanova, M.F., Buxhoeveden, D.P., Switala, A.E. et al., Minicolumnar pathology in autism, Neurology, 2002; 58: 428-432.
21. Chini, B., Raimond, E., Elgoyhen, A.B. et al., Molecular cloning and chromosomal localization of the human alpha 7-nicotinic receptor subunit gene (CHRNA 7), Genomics, 1994; 19: 379-381.
22. Chrousos, G.P. and Gold, P.W., The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis, JAMA, 1992; 267: 1244-1252.
23. Cook, E.H., Leventhal, B.L., and Freedman, D.X., Free serotonin in plasma: autistic children and their first-degree relatives, Biol Psychiatry, 1988; 24: 488-491.
24. Cook, E.H., Autism: review of neurochemical investigation, Synapse 1990; 6: 292-308.
25. Courchesne, E., Karns, C.M., Davis, H.R. et al., Unusual brain growth patterns in early life in patients with autistic disorder, Neurology, 2001; 57: 245-254.
26. Court, J.A., Perry, E.K., Spurden, D. et al., The role of the cholinergic system in the development of the human cerebellum, Dev Brain Res., 1995; 90: 159-167.
27. da Penha Berzaghi, M., Cooper, J., Castren, E. et al., Expression of alpha 7 nicotinic receptors during postnatal development of the cerebellum, Brain Res Dev Brain Res., 1997; 98: 125-133.
28. Eccles, J.C., Ito, M., and Szentagothai, J., The Cerebellum as a Neuronal Machine, New York: Springer-Verlag, 1967.
29. Ernst, M., Zametkin, A.J., Matochik, J.A. et al., Low medial prefrontal dopaminergic activity in autistic children, Lancet, 1997; 350(9078): 638.
30. Fatemi, H., Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly, Mol Psychiatry, 2001; 6: 129-133.
31. Gottesmann, I.I. and Gould, T.D., The endophenotype concept in psychiatry: etymology and strategic intentions, Am J Psychiatry, 2003; 160: 636-645.
32. Granon, S., Faure, P., and Changeux, J.P., Executive and social behaviors under nicotinic receptor regulation, Proc Natl Acad Sci U S A, 2003; 100: 9596-9601.
33. Greenfield, J.G., The Spino-Cerebellar Degenerations, Springfield, IL: CC Thomas, 1954.
34. Hashimoto, Y., Abiru, Y., Nishio, C. et al., Synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor on cultured basal forebrain cholinergic neurons from postnatal 2-week old rats, Brain Res Dev Brain Res., 1999; 115: 25-32.
35. Haznedar, M.M., Buchsbaum, M.S., Wei, T.C. et al., Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging, Am J Psychiatry, 2000; 157: 1994-2001.
36. Hellstrom-Lindahl, E. and Court, J.A., Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging, Behav Brain Res., 2000; 113: 159-168.
37. Hellstrom-Lindahl, E., Gorbounova, O., Seiger, A. et al., Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord, Brain Res Dev Brain Res., 1998; 108: 147-160.
38. Herbert, M.R., Ziegler, D.A., Makris, N. et al., Localization of white matter volume increase in autism and developmental language disorder, Ann Neurol., 2004; 55: 530-540.
39. Hohmann, C.F. and Berger-Sweeney, J., Cholinergic regulation of cortical development and plasticity: new twists to an old story, Perspect Dev Neurobiol., 1998; 5: 401-425.
40. Holmes, G. and Stewart, T.G., On the connection of the inferior olives with the cerebellum in man, Brain, 1908; 31: 125-137.
41. Janusonis, S., Gluncic, V., and Rakic, P., Early serotonergic projections to Cajal-Retzius cells: relevance for cortical development, J Neurosci., 2004; 24: 1652-1659.
42. Kanner, L., Autistic disturbances of affective contact, Nerv Child, 1943; 2: 217-250.
43. Kemper, T.L. and Bauman, M.L., Neuropathology of infantile autism, J Neuropath Exp Neurol., 1998; 57: 645-652.
44. Kemper, T.L., Neuropathology of autism, in Golden, J.A. and Harding, B.N., Eds., Developmental Neuropathology, Basel, Switzerland: International Society of Neuropathology, 2004; 40: 349-352.
45. Koul, O., Myelin and autism, in Bauman, M.L. and Kemper, T.L., Eds., The Neurobiology of Autism, 2nd ed., Baltimore, MD: Johns Hopkins University Press, 2005, pp. 150-163.
46. Kumari, V., Gray, J.A., Fytche, D.H. et al., Cognitive effects of nicotine in humans: and fMRI study, Neuroimage, 2003; 19: 1002-1003.
47. Lainhart, J.E., Piven, J., Wzorek, M. et al., Macrocephaly in children and adults with autism, J Am Acad Child Adolesc Psychiatry, 1997; 36: 282
48. Lamb, J.A., Moore, J., Bailey, A. et al., Autism: recent molecular genetic advances, Hum Mol Genet., 2000; 4: 861-865.
49. Lan, C.T., Wen, C.Y., Tan, C.K. et al., Multiple origins of cerebellar cholinergic afferents from lower brainstem in the gerbil, J Anat., 1995; 186: 549-561.
50. Lawrence, Y., Kemper, T.L., Bauman, M.L. et al., Increased density of parvalbumin labeled hippocampal interneurons in autism (abstract), IMFAR, Boston, MA, May 5, 2005.
51. Leboyer, M., Bellivier, F., Nosten-Bertrand, M. et al., Psychiatric genetics: search for phenotypes, Trends Neurosci., 1998; 21: 102-105.
52. Lee, M., Martin-Ruiz, C., Graham, A. et al., Nicotinic receptor abnormalities in the cerebellar cortex in autism, Brain, 2002; 125: 1483-1495.
53. Lena, C., Popa, D., Grailhe, R. et al., Beta 2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice, J Neurosci., 2004; 24: 5711-5718.
54. Lotspeich, L.J. and Ciaranello, R.D., The neurobiology and genetics of infantile autism, Int Rev Neurobiol., 1993; 35: 87-129.
55. Martin-Ruiz, C.M., Lee, M., Perry, R.H. et al., Molecular analysis of nicotinic receptor expression in autism, Brain Res Mol Brain Res., 2004; 123: 81-90.
56. Martineau, J., Herault, J., Petit, E. et al., Catecholaminergic metabolism and autism, Dev Med Child Neurol., 1994; 8: 688-697
57. Marubio, L.M., del Mar Arroyo-Jamenez, M., Cordero-Erausquin, M. et al., Reduced antinociception in mice lacking neuronal nicotinic receptor subunits, Nature, 1999; 398(6730): 805-810.
58. McBride, P.A., Anderson, G.M., Hertzig, M.E. et al., Serotonergic responsivity in male young adults with autistic disorder: results of a pilot study, Arch Gen Psychiatry, 1989; 46: 213-221.
59. McBride, P.A., Anderson, G.M., and Shapiro, T., Autism research: bringing together approaches to pull apart the disorder, Arch Gen Psychiatry, 1996; 53: 980-983.
60. McGehee, D.S., Nicotinic receptors and hippocampal synaptic plasticity … it’s all in the timing, Trends Neurosci., 2002; 25: 171-172.
61. Minderaa, R.B., Anderson, G.M., and Volkmar, F.R. et al., Neurochemical study of dopamine functioning in autistic and normal subjects, J Am Acad Child Adolesc Psychiatry, 1989; 28: 200-206.
62. Minderaa, R.B., Anderson, G.M., and Volkmar, F.R. et al., Noradrenergic and adrenergic functioning in autism, Biol Psychiatry, 1994; 36: 237-241.
63. Minshew, N.J., Goldstein, G., Siegel, D.J. et al., Neuropsychological functioning in autism: profile of a complex information processing disorder, J Int Neuropsychol Soc., 1997; 3: 303-316.
64. Mirza, N.R. and Stoleman, I.P., The role of nicotinic and muscarinic acetylcholine receptors in attention, Psychopharmacology (Berl), 2000; 148: 243-250.
65. Miyazaki, K., Narita, N., Sakuta, R. et al., Serum neurotrophin concentrations in autism and mental retardation: a pilot study, Brain Dev., 2004; 26: 292-295.
66. Mosconi, M., Cody, H., Poe, M. et al., Amygdala and hippocampus enlargement in young children with autism, IMFAR, Boston, MA, May 6, 2005.
67. Mukaetova-Ladinska, E.B., Arnold, H., Jaros, E. et al., Depletion of MAP-2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals, Neruopathol Appl Neurobiol., 2004; 30: 615-623.
68. Mulder, E.J., Anderson, G.M., Kema, I.P. et al., Platelet serotonin in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution and behavioral correlates, J Am Acad Child Adolesc Psychiatry, 2004; 43: 491-499.
69. Muller, R.A., Chugani, D.C., Behen, M.E. et al., Impairment of dento-thalamo-cortical pathway in autistic men: language activation data from positron emission tomography, Neurosci Lett., 1998; 245: 1-4.
70. Narayan, M., Srinath, S., Anderson, G.M., and Meundi, D.B., Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism, Biol Psychiatry, 1993; 33: 630-635.
71. Nelson, K.B., Grether, J.K., Crien, L.A. et al., Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation, Ann Neurol., 2001; 49: 597-606.
72. Norman, R.M., Cerebellar atrophy associated with etat marbre of the basal ganglia, J Neurol Psychiatry, 1940; 3: 311-318.
73. Novotny, S., Hollander, E., Allen, A. et al., Increased growth hormone response to sumatriptan challenge in adult autistic disorders, Psychiatry Res., 2000; 94: 173-177.
74. Perry, E.K., Walker, M., Grace, J. et al., Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci., 1999; 22: 273-280.
75. Perry, E.K., Lee, M.L., Martin-Ruiz, C.M. et al., Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain, Am J Psychiatry 2001; 158: 1058-1066.
76. Perry, E.K. and Perry, R.H., Neurochemistry of consciousness: cholinergic pathologies in the human brain, Prog Brain Res., 2004; 145: 287-299.
77. Purcell, A.E., Jeon, O.H., Zimmerman, A.W. et al., Postmortem brain abnormalities of the glutamate neurotransmitter system in autism, Neurology 2001; 57: 1618-1628.
78. Rakic, P. and Sidman, R.L., Histogenesis of the cortical layers in human cerebellum particularly in the lamina dissecans, J Comp Neurol., 1970; 139: 473-500.
79. Rakic, P., Neuron-glia relationship during granule cell migration in developing cerebellar cortex: a Golgi and electron microscopic study in Macacus rhesus, J Comp Neurol., 1971; 141: 282-312.
80. Raymond, G.V., Bauman, M.L., and Kemper, T.L., Hippocampus in autism: a Golgi analysis, Acta Neuropathologica, 1996; 91: 117-119.
81. Ritvo, E.R., Freeman, B.J., Scheibel, A.B. et al., Lower Purkinje cell counts in the cerebella of four autistic subjects: Initial findings of the UCLA-NSAC autopsy research report, Am J Psychiatry, 1986; 146: 862-866.
82. Rodier, P.M., Ingram, J.L., Tisdale, B. et al., Embryological origins of autism: developmental abnormalities of the cranial nerve nuclei, J Comp Neurol., 1996; 36: 351-356.
83. Rosene, D.L. and van Hoesen, G.W., The hippocampal formation in the primate brain, in Cerebral Cortex, Jones, E.G. and Peters, A., Eds., Vol. 6, Plenum Press, New York, 1987, pp. 345-450.
84. Rosengren, L.E., Ahlsen, G., Belfrage, M. et al., A sensitive ELISA for glial fibrillary acidic protein: application in CSF in children, J Neurosci Methods, 1992; 44: 113-119.
85. Ross, S.A., Wong, J.Y., Clifford, J.J. et al., Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse, J Neurosci., 2000; 20: 6431-6441.
86. Sabbagh, M.N., Reid, R.T., Corey-Brown, J. et al., Correlation of nicotinic binding with neurochemical markers in Alzheimer’s disease, J Neural Transm., 1998; 105: 709-717.
87. Salgado-Commissariat, D., Rosenfield, D.B., and Helekar, S.A., Nicotine-mediated plasticity in robust nucleus of the archistriatum of the adult zebra fish, Brain Res., 2004; 1018: 97-105.
88. Sarter, M. and Bruno, J.P., Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents, Neuroscience, 2000; 95: 933-952.
89. Schain, R.J. and Freedman, D.X., Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children, J Pediatr., 1961; 58: 315-320.
90. Schultz, R.T. and Anderson, G.M., The neurobiology of autism and the pervasive developmental disorders, in Neurobiology of Mental Illness, 2nd ed., Eds., Nestler, E. and Charney, D., Oxford University Press, New York, 2004, pp. 954-967
91. Schumann, C.M., Hamstra, J., Goodlin-Jones, B.L. et al., The amygdala is enlarged in children but not adolescents with autism: the hippocampus is enlarged at all ages, J Neurosci., 2004; 24(28): 6392-6401.
92. Schumann, C. and Amaral, D., No difference in the number of neurons in the amygdala in postmortem cases of autism: a stereologic study, IMFAR, Boston, MA, May 6, 2005.
93. Semagor, E., Eglen, S.J., and Wong, R.O.L., Development of retinal ganglon cell structure and function, Prog Ret and Eye Res., 2001; 20: 139-174.
94. Skuse, D.H., Endophenotypes and child psychiatry, Br J Psychiatry, 2001; 178: 395-396.
95. Sparks, B.F., Friedman, S.D., Shaw, D.W. et al., Brain structural abnormalities in young children with autism spectrum disorder, Neurology, 2002; 59(2): 184-192.
96. 125 l) a-bungarotoxin binding, J Chem Neuroanatomy, 1997; 13: 105-113.
97. Sweeten, T.L., Posey, D.J., Shekhar, A. et al., The amygdala and related structures in the pathophysiology of autism, Pharmacol Biochem Behav., 2002; 71: 449-455.
98. Tice, M.A., Hashemi, T., Taylor, L.A. et al., Distribution of muscarinic receptor subtypes in rat brain from postnatal to old age, Brain Res Dev Brain Res., 1996; 92: 70-76.
99. Tordjman, S., Anderson, G.M., McBride, P.A. et al., Plasma B-endorphin, adrenocorticotropin hormone, and cortisol in autism, J Child Psychol Psychiatry, 1997; 38: 705-715.
100. Tordjman, S., Antoine, C., Cohen, D.J. et al., Study of the relationships between self-injurious behavior and pain reactivity in infantile autism, Encephale, 1999; 25: 122-134.
101. Tsatsanis, K.D., Rourke, B.P., Klin, A. et al., Reduced thalamic volume in high-functioning individuals with autism, Biol Psychiatry, 2003; 53: 121-129.
102. Van Kampen, M., Selbach, K., Schneider, R. et al., AR-R 17779 improves social recognition in rats by activation of nicotinic alpha 7 receptors, Psychopharmacology (Berl), 2004; 172: 375-383.
103. Waterhouse, L., Fein, D., and Modahl, C., Neurofunctional mechanisms in autism, Psychol Rev., 1996; 103: 457-489.
104. Wenk, G.L., Naidu, S., Casanova, M.F. et al., Altered neurochemical markers in Rett’s syndrome, Neurology, 1991; 41: 1753-1756.
105. Wenk, G.L. and Mobley, S.L., Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions, Neuroscience 1996; 73: 79-84.
106. Wesnes, K., Warburton, D.M., and Matz, B., Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task, Neuropsychology, 1983; 9: 41-44.
107. Wesnes, K. and Warburton, D.M., Effects of scopolamine and nicotine on human rapid information processing performance, Psychopharmacology (Berl), 1984; 82: 147-150.
108. Yakovlev, P.I. and Lecours, A.R., Myelogenetic cycles of regional maturation of the brain, in Regional Development of the Brain in early Life, Minkowski, A., Ed., 1967, 3-70.
109. Zoli, M., Picciotto, M.R., Ferrari, R. et al., Increased neurodegeneration during aging in mice lacking high-affinity nicotine receptors, Embo J., 1999; 18: 1235-1244.